The human relevance of information on carcinogenic modes of action: Overview

被引:67
作者
Cohen, SM
Meek, ME
Klaunig, JE
Patton, DE
Fenner-Crisp, PA
机构
[1] ILSI Risk Sci Inst, Washington, DC 20005 USA
[2] Univ Nebraska, Med Ctr, Omaha, NE USA
[3] Hlth Canada, Ottawa, ON K1A 0L2, Canada
[4] Indiana Univ, Sch Med, Indianapolis, IN USA
关键词
carcinogenic mode of action; human relevance of animal tumors; peroxisome proliferation; PPAR alpha agonists; risk assessment;
D O I
10.1080/713608371
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Risk assessment policies and practice place increasing reliance on mode of action (MOA) data to inform conclusions about the human relevance of animal tumors. In June 2001. the Risk Science Institute of the International Life Sciences Institute formed a workgroup to study this issue. The workgroup divided into two subgroups, one developing and testing a "framework" for MOA relevance analysis and the other conducting an in-depth analysis of peroxisome proliferation-activated receptor (PPAR)a activation as the MOA for some animal carcinogens. This special issue of Critical Reviews in Toxicology presents the scientific reports emerging from this activity. These reports serve several purposes. For risk assessors in and out of government, they offer a new human relevance framework (HRF) that complements and extends existing guidance from other organizations. Regarding the specific MOA for peroxisome proliferating chemicals, these reports offer a state-of-the-science review of this important MOA and its role in tumorigenesis in three different tissues (liver, testis, and pancreas). The case studies in these reports present models for using MOA information to evaluate the hazard potential for humans. The cases also illustrate the substantial impact of a complete human relevance analysis, as distinct from an animal MOA analysis alone, on the nature and scope of risk assessment.
引用
收藏
页码:581 / 589
页数:9
相关论文
共 11 条
  • [1] [Anonymous], 1999, GUID CARC RISK ASS
  • [2] MECHANISTICALLY-BASED HUMAN HAZARD ASSESSMENT OF PEROXISOME PROLIFERATOR-INDUCED HEPATOCARCINOGENESIS
    ASHBY, J
    BRADY, A
    ELCOMBE, CR
    ELLIOTT, BM
    ISHMAEL, J
    ODUM, J
    TUGWOOD, JD
    KETTLE, S
    PURCHASE, IFH
    [J]. HUMAN & EXPERIMENTAL TOXICOLOGY, 1994, 13 : S1 - S117
  • [3] Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats
    Biegel, LB
    Hurtt, ME
    Frame, SR
    O'Connor, JC
    Cook, JC
    [J]. TOXICOLOGICAL SCIENCES, 2001, 60 (01) : 44 - 55
  • [4] Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?
    Cattley, RC
    DeLuca, J
    Elcombe, C
    Fenner-Crisp, P
    Lake, BG
    Marsman, DS
    Pastoor, TA
    Popp, JA
    Robinson, DE
    Schwetz, B
    Tugwood, J
    Wahli, W
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1998, 27 (01) : 47 - 60
  • [5] NATURE OF HEPATOMEGALIC EFFECT PRODUCED BY ETHYL-CHLOROPHENOXY-ISOBUTYRATE IN RAT
    HESS, R
    STAUBLI, W
    RIESS, W
    [J]. NATURE, 1965, 208 (5013) : 856 - +
  • [6] *INT AG RES CANC, 1992, IARC MON EV CARC RIS, V54, P13
  • [7] INTERFACE BETWEEN ADAPTIVE AND NEOPLASTIC GROWTH IN THE PANCREAS
    LONGNECKER, DS
    [J]. GUT, 1987, 28 : 253 - 258
  • [8] NRC: National Research Council, 1994, SCI JUDGM RISK ASS C
  • [9] REDDY JK, 1976, CANCER RES, V36, P1211
  • [10] IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis
    Sonich-Mullin, C
    Fielder, R
    Wiltse, J
    Baetcke, K
    Dempsey, J
    Fenner-Crisp, R
    Grant, D
    Hartley, M
    Knaap, A
    Kroese, D
    Mangelsdorf, I
    Meek, E
    Rice, JM
    Younes, M
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2001, 34 (02) : 146 - 152